Clinical trials
Recruiting Multiple Sclerosis, Relapsing-Remitting trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
18 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2020 | 1 |
| 2021 | 2 |
| 2023 | 3 |
| 2024 | 1 |
| 2025 | 6 |
| 2026 | 5 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 18 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Georgia State University | 2 |
| Shirley Ryan AbilityLab | 2 |
| University of California, San Francisco | 2 |
| Bristol-Myers Squibb | 1 |
| Cedars-Sinai Medical Center | 1 |
| Cionic, Inc. | 1 |
| National Institute of Allergy and Infectious Diseases (NIAID) | 1 |
| Northwestern University | 1 |
| SetPoint Medical Corporation | 1 |
| The University of Texas at Dallas | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Multiple Sclerosis, Relapsing-Remitting | 18 |
| Multiple Sclerosis | 13 |
| Multiple Sclerosis, Chronic Progressive | 8 |
| Hypoxia | 2 |
| Autoimmune Diseases of the Nervous System | 1 |
| Cognitive Dysfunction | 1 |
| Disease Progression | 1 |
| Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease | 1 |
| Nervous System Diseases | 1 |
| Neuroinflammatory Diseases | 1 |
Trials
Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.